Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2026 04:00 ET | Source: Amphista Therapeutics

Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program

Cambridge, UK, 24th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the...
April 24, 2026 04:00 ET | Source: Levicept

Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis

SANDWICH, United Kingdom, April 24, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in-class treatment for osteoarthritis (OA), will...
April 24, 2026 03:54 ET | Source: Mordor Intelligence

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence

Hyderabad, April 24, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the tissue engineering market size is projected to grow from USD 15.01 billion in 2026 to USD 27.59 billion by 2031,...
April 23, 2026 22:04 ET | Source: FDA

FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program

White Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV)...
April 23, 2026 16:05 ET | Source: Trevi Therapeutics, Inc.

Trevi Therapeutics to Participate in Upcoming May Events

NEW HAVEN, Conn., April 23, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral...
April 23, 2026 15:53 ET | Source: The ROOT Brands

The ROOT Brands Earns National Recognition for Patent‑Driven Wellness Innovation and Science‑Backed Consumer Products

Franklin, Tennessee, April 23, 2026 (GLOBE NEWSWIRE) -- The ROOT Brands, a patent‑driven consumer wellness company built on science‑backed innovation and cellular health research, announced today...
April 23, 2026 15:46 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

Regeneron will provide Otarmeni™ (lunsotogene parvec-cwha), its recently approved gene therapy for an ultra-rare form of genetic hearing loss, for free in the U.S. Regeneron will lower Medicaid...
April 23, 2026 15:45 ET | Source: Oxford Treatment Center

This Alcohol Awareness Month, Oxford Treatment Center Raises Red Flag, Citing Significant Rise in Patients Seeking Help for Alcohol Addiction

Oxford Treatment Center sounds warning this Alcohol Awareness Month, citing rise in patients seeking alcohol addiction treatment.
April 23, 2026 15:38 ET | Source: Cook County Health

Cook County Health Recognizes 60th Anniversary of Trauma Unit

Chicago, IL, April 23, 2026 (GLOBE NEWSWIRE) -- On April 23, Cook County Health proudly celebrated the 60th anniversary of the Trauma & Burn Department at John H. Stroger, Jr. Hospital, honoring...
April 23, 2026 14:03 ET | Source: BCC Research LLC

AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption

AI-driven monitoring is increasingly used to improve precision, efficiency, and safety in spine, neurosurgical, and ENT procedures.